Denied

No. 24-292

Salix Pharmaceuticals, Ltd., et al. v. Norwich Pharmaceuticals Inc.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

DISTRIBUTED for Conference of 12/13/2024.

Reply of petitioners Salix Pharmaceuticals, Ltd., et al. filed. (Distributed)

Brief of respondent Norwich Pharmaceuticals Inc. in opposition filed.

Motion to extend the time to file a response is granted and the time is extended to and including November 14, 2024.

Motion to extend the time to file a response from October 15, 2024 to November 14, 2024, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due October 15, 2024)

Parties

Salix Pharmaceuticals, Ltd.; Salix Pharmaceuticals, Inc.; Bausch Health Ireland Ltd., Petitioner, represented by William Robert Peterson

Norwich Pharmaceuticals Inc., Respondent, represented by Thomas Knut Hedemann

 
Last updated: April 18, 2026